about
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse modelNon-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy.Quantum dot penetration into viable human skin.Applications of multiphoton tomographs and femtosecond laser nanoprocessing microscopes in drug delivery research.Enhanced sonophoretic delivery of 5-aminolevulinic acid: preliminary human ex vivo permeation data.Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.Multiphoton microscopy applications in nanodermatology.Automated detection of actinic keratoses in clinical photographs.Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin samplingMicroneedle enhanced delivery of cosmeceutically relevant peptides in human skin.High-contrast coherent terahertz imaging of porcine tissue via swept-frequency feedback interferometry.Automated Segmentation of Skin Strata in Reflectance Confocal Microscopy Depth Stacks.Concurrent Reflectance Confocal Microscopy and Laser Doppler Flowmetry to Improve Skin Cancer Imaging: A Monte Carlo Model and Experimental Validation.Fractional laser-assisted drug uptake: Impact of time-related topical application to achieve enhanced delivery.Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium.Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathyHyperoxia inhibits several critical aspects of vascular development.Vascular precursors in developing human retina.Cutaneous short-interfering RNA therapy.Toxicity of nanomaterials to the eye.Nanoparticles and microparticles for skin drug delivery.Nanoparticle-delivered biosensor for reactive oxygen species in diabetes.Therapeutic gold, silver, and platinum nanoparticles.Reflectance confocal microscopy: hallmarks of keratinocyte cancer and its precursors.Formulation design for topical drug and nanoparticle treatment of skin disease.RNA-seq reveals more consistent reference genes for gene expression studies in human non-melanoma skin cancers.The future of keratinocyte skin cancer surveillance: automated image analysis to identify and monitor keratinocyte dysplasia.Minimally invasive microbiopsies: a novel sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani.A blueprint for staging of murine melanocytic lesions based on the Cdk4 ( R24C/R24C ) ::Tyr- NRAS ( Q ) ( 61K ) model.Effective cutaneous vaccination using an inactivated chikungunya virus vaccine delivered by Foroderm.Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice.Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells.The initial fetal human retinal vasculature develops by vasculogenesis.The embryonic human choriocapillaris develops by hemo-vasculogenesis.Microbiopsy Biomarker Profiling in a Superficial Melanoma Resembling a Pigmented Basal Cell Carcinoma.The effect of formulation on the penetration of coated and uncoated zinc oxide nanoparticles into the viable epidermis of human skin in vivo.Three-dimensional modelling for estimation of nevus count and probability of nevus-melanoma progression in a murine model.Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology.Effects of ex vivo skin microbiopsy on histopathologic diagnosis in melanocytic skin lesions.A plea for biobanking of all equivocal melanocytic proliferations.
P50
Q27330580-6FFDCDD8-2B3E-401C-81EF-6F19FD6A9F05Q33800463-1BF13704-40D1-4656-8789-533BC6A5D3C0Q33860137-4E355F38-DBC8-4F8C-BE7D-2F6F18B3B28FQ33880217-85FD4665-54A7-442F-8C43-AC5C71E8363CQ34294126-CCA33A2A-B139-42CC-B92A-AF21A1954EB7Q34396026-C22C831F-C831-4908-93E7-19F01E26D61CQ34413493-F3215F64-ABCF-4B6A-9136-ACC4DEABA20AQ35006877-A0940D75-9A17-43A7-9C2A-EE4D19953CBEQ35120409-EF930534-7376-4C29-A967-E2B1AB36E97FQ35208322-D7B431A8-40E5-4550-B244-5F7F5804A621Q35451202-46034CB1-645D-4705-BF4F-9AA3219F673AQ35992477-0041255E-7FFC-4295-94BE-D4B62B6888C2Q36123716-5FCB7782-64B4-4F31-AF33-C0D799A45B13Q36203859-4FCAA9D1-39FC-4FDE-AC19-E2E042D2422AQ36758812-79366604-9C82-492C-B70D-B7851896A122Q37029390-60DCAF9C-76DB-444E-9CB4-C430163AFC34Q37088188-87B3A677-B859-4FB1-83C5-6F74380CC224Q37090288-B3081108-93C2-4672-AC62-4705EB2AA939Q37639312-5B1C65D4-0131-4CD5-AE32-6F9D8F4401D5Q37676123-6830B133-EB6E-4E94-AC79-F3C3BAA099BAQ37840318-E7C32B89-534E-43E3-BA41-57DA360B2361Q38271398-367401A9-42EC-40E1-B59A-7EA615E79096Q38292983-88040DE1-85F8-49A5-A679-DD1543680DEAQ38308397-A4062C13-32D2-4A49-A8FB-BEC83438FCBCQ38358872-10042193-3790-4746-AA91-E3E72F2F699EQ38602807-17B837F2-AFB8-4F7C-98AF-6AA3D6F98892Q39064085-413C1D58-5F4C-41CB-8F52-F37DAC00EF5AQ39139044-3DD60FFB-D64B-4396-8F11-DC4780EDB36DQ40044674-4FC4DB1C-FE51-4D42-8883-B9473806A54CQ40142279-8698AB76-FF28-4499-A761-935EE9F8CA4BQ40352616-FBC79EE1-A015-4A89-BBD6-244835903B85Q40735235-80C4D0B1-E40A-44D9-B586-C84B87B44DD9Q40812273-F1543B5C-F7B2-4072-B24E-FAF5E6936E2BQ41808196-6B7C00F1-2F10-4DB1-B8F9-550404BA3084Q42505685-41E1CEDD-CBC3-40D5-B07F-D9C17F345C56Q43706218-C8091B94-F834-4448-A03F-C81DC97CA35FQ44427640-71B6B5A5-2198-477A-AEE2-3180B24BEDF5Q44476073-30414AE0-18BE-45B8-95FB-DE8E8B1DB502Q44619210-33BB76AE-01A6-4D39-9EAA-89449CF5AA04Q44823735-28AEA11B-1DE0-443B-991D-8C5A1AB0F995
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tarl W. Prow
@ast
Tarl W. Prow
@en
Tarl W. Prow
@es
Tarl W. Prow
@nl
Tarl W. Prow
@sl
type
label
Tarl W. Prow
@ast
Tarl W. Prow
@en
Tarl W. Prow
@es
Tarl W. Prow
@nl
Tarl W. Prow
@sl
altLabel
Tarl W. Prow
@en
prefLabel
Tarl W. Prow
@ast
Tarl W. Prow
@en
Tarl W. Prow
@es
Tarl W. Prow
@nl
Tarl W. Prow
@sl
P1053
A-4764-2010
P106
P1153
6507307431
P1960
VDnv4PEAAAAJ
P2038
P21
P31
P3829
P496
0000-0003-2892-6238
P569
2000-01-01T00:00:00Z